Eam Global Investors LLC Madrigal Pharmaceuticals, Inc. Transaction History

Eam Global Investors LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$231.06 - $307.08 $1.36 Million - $1.8 Million	5,874 Added 104.22%	11,510 $2.79 Million
Q4 2022 Feb 14, 2023	BUY	$58.39 - $296.54 $329,086 - $1.67 Million	5,636 New	5,636 $1.64 Million
Q4 2018 Feb 13, 2019	SELL	$94.77 - $215.54 $316,531 - $719,903	-3,340 Closed	0 $0
Q3 2018 Nov 08, 2018	SELL	$207.3 - $300.31 $353,653 - $512,328	-1,706 Reduced 33.81%	3,340 $715,000
Q2 2018 Aug 03, 2018	SELL	$101.55 - $313.9 $310,133 - $958,650	-3,054 Reduced 37.7%	5,046 $1.41 Million
Q1 2018 Jun 04, 2018	BUY	$93.35 - $149.04 $756,135 - $1.21 Million	8,100 New	8,100 $946,000

337

22.3M

987K

960K

Ticker MDGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 17,103,400
Market Cap $5.77B
Description
Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...

Get notified when there are updates to the investment portfolio of Eam Global Investors LLC, based on Form 13F filings with the SEC.

Stay updated on Eam Global Investors LLC with notifications on news.